acitretin trade names soriatane neotigason secondgeneration retinoid taken orally typically used acitretin oral retinoid used treatment severe resistant psoriasis potential problems severe side effects generally used severe cases psoriasis unresponsive treatments binds nuclear receptors regulates gene transcription induce keratinocyte differentiation reduce epidermal hyperplasia leading slowing cell reproduction acitretin readily absorbed widely distributed oral administration therapeutic effect occurs two four weeks longer patients received medication advised giving blood least three years due risk birth acitretin highly teratogenic noted possibility severe birth defects used pregnant women women planning get pregnant within years following use acitretin sexually active women childbearing age use acitretin also use least two forms birth control concurrently men women use donate blood three years using possibility blood might used pregnant patient cause birth defects addition may cause nausea headache itching dry red flaky skin dry red eyes dry chapped lips swollen lips dry mouth thirst cystic acne hair metabolite etretinate used prior introduction acitretin etretinate discontinued narrow therapeutic index well long elimination halflife days making dosing difficult contrast acitretins halflife approximately days however acitretin reverse metabolised etretinate extremely long halflife women must avoid becoming pregnant least three discontinuing acitretin therefore acitretin generally recommended women childbearing age risk becoming pregnant httpsenwikipediaorgwikiacitretin